Clinical trials

  • ASCIMINIB HYDROCHLORIDE for Philadelphia chromosome-positive chronic myeloid leukemia (chronic phase)|Juvenile chronic myeloid leukemia
  • Adalimumab for Inflammatory bowel disease (IBD)|Ulcerative colitis|Crohn's disease
  • ANTI-GD2-800CW for Neuroblastoma
  • MEPOLIZUMAB for Eosinophilic granulomatosis with polyangiitis (EGPA)|Granulomatosis with polyangiitis (GPA)|Chronic rhinosinusitis with nasal polyps (CRSwNP)|Severe asthma|Healthy control
  • IVOSIDENIB for Acute myeloid leukaemia | IDH1-mutated acute myeloid leukaemia
  • Doravirine; Islatravir for HIV-1 infection
  • DURVALUMAB for Non-small cell lung cancer | Stage III unresectable non-small cell lung cancer
  • GADOPICLENOL for Steno-occlusive vascular disease|Renovascular hypertension (suspected)
  • Pemetrexed disodium for Non-small cell lung cancer (non-squamous, metastatic / stage IV)
  • erdafitinib for Non-muscle-invasive bladder cancer | Muscle-invasive bladder cancer
  • LIDOCAINE HYDROCHLORIDE for Sickle cell disease
  • Gozetotide for Prostate cancer